Discriminative stimulus effects ofd-amphetamine, methylphenidate, and diazepam in humans Stephen J. HeishmanJack E. Henningfield Original Investigations Pages: 436 - 442
Neuroendocrine responses to single oral doses of remoxipride and sulpiride in healthy female and male volunteers Christer von BahrFrits-Axel WieselStephan Ogenstad Original Investigations Pages: 443 - 448
LY 171555-induced hyperdefensiveness in the mouse does not implicate benzodiazepine receptors Catherine BelzungSimona CabibStefano Puglisi-Allegra Original Investigations Pages: 449 - 454
Animal model for investigating the anxiogenic effects of self-administered cocaine Aaron EttenbergTimothy D. Geist Original Investigations Pages: 455 - 461
Effects of MK-801, a non-competitive NMDA antagonist, on linguopharyngeal events in rats Luis A. MarcoRajani S. JoshiRobert B. Chronister Original Investigations Pages: 462 - 466
Importance of delta opioid receptors in maintaining high alcohol drinking J. C. FroehlichM. ZweifelT. -K. Li Original Investigations Pages: 467 - 472
Anxiolytic effects of benzodiazepines in amygdala-lesioned rats Elna YadinEarl ThomasHolly L. Grishkat Original Investigations Pages: 473 - 479
Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats Pamela E. PaulsonDianne M. CampTerry E. Robinson Original Investigations Pages: 480 - 492
Opioid δ agonists and endogenous enkephalins induce different emotional reactivity than μ agonists after injection in the rat ventral tegmental area G. Calenco-ChoukrounV. DaugéB. P. Roques Original Investigations Pages: 493 - 502
Drugs acting at D-1 and D-2 dopamine receptors induce identical purposeless chewing in rats which can be differentiated by cholinergic manipulation P. CollinsC. L. E. BroekkampC. D. Marsden Original Investigations Pages: 503 - 512
Early life protein malnutrition changes exploration of the elevated plus-maze and reactivity to anxiolytics S. S. AlmeidaL. M. de OliveiraF. G. Graeff Original Investigations Pages: 513 - 518
Differentiating the sedative, psychomotor and amnesic effects of benzodiazepines: a study with midazolam and the benzodiazepine antagonist, flumazenil H. Valerie CurranBrian Birch Original Investigations Pages: 519 - 523
Effect of chronic treatment with 8-OH-DPAT in the forced swimming test requires the integrity of presynaptic serotonergic mechanisms L. CervoR. Samanin Original Investigations Pages: 524 - 528
Evaluation of the dependence potential of the selective 5-H1A agonist ipsapirone in rats and of its effects on benzodiazepine withdrawal A. J. GoudieM. J. Leathley Original Investigations Pages: 529 - 537
Psychophysiological reactions in methadone maintenance patients do not correlate with methadone plasma levels Norbert LoimerRainer SchmidOtto Presslich Original Investigations Pages: 538 - 540
Comparison of the behavioural effects of an adenosine A1/A2-receptor antagonist, CGS 15943A, and an A1-selective antagonist, DPCPX Guy GriebelMartine Saffroy-SpittlerJean-Jacques Bourguignon Original Investigations Pages: 541 - 544
Comparison of the amnesic effects of midazolam and diazepam Maria J. HennessyKenneth C. KirkbyIain M. Montgomery Original Investigations Pages: 545 - 550
CSF monoamine metabolite concentrations vary according to age, rearing, and sex, and are influenced by the stressor of social separation in rhesus monkeys J. D. HigleyS. J. SuomiM. Linnoila Original Investigations Pages: 551 - 556
Response to selection for ethanol-induced locomotor activation: genetic analyses and selection response characterization Tamara J. PhillipsSue Burkhart-KaschJohn C. Crabbe Original Investigations Pages: 557 - 566
Non-reversal of scopolamine- or age-related EEG changes by ondansetron, methysergide or alaproclate Paavo Riekkinen Jr.Jouni SirviöPaavo Riekkinen Original Investigations Pages: 567 - 570
Anxiety in the pathogenesis of primate infant abuse: a pharmacological study Alfonso TroisiFrancesca R. D'Amato Letter To The Editors Pages: 571 - 572
32nd Annual Meeting of the Scandinavian Society for Psychopharmacology Copenhagen, Denmark April 10–12, 1991 Abstracts Abstract Pages: B1 - B14